Oracle price target lowered to $170 from $175 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Oracle (ORCL) to $170 from $175 and keeps an Equal Weight rating on the shares. Oracle shares saw a “muted investor reaction” to earnings despite bookings being up 67% year-over-year due to questions on durability of the training business, rising margin impacts, and soft near-term results. The roughly $130B RPO balance should support ramping revenue growth into FY26 and FY27, but more confidence in margins is “likely key to unlocking shares,” the analyst tells investors.